S 1001

  • New York Senate Bill
  • 2023 Regular Session
  • Introduced in Senate
  • Passed Senate Jun 06, 2023
  • Passed Assembly Jun 06, 2024
  • Signed by Governor Jun 28, 2024

Prohibits insurers from restricting or imposing delays in the distribution of antiretroviral prescription drugs prescribed to a person for HIV or AIDS

Abstract

Prohibits insurers from restricting or imposing delays in the distribution of antiretroviral prescription drugs prescribed to a person for the treatment or prevention of the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS).

Bill Sponsors (4)

Votes


Actions


Jun 28, 2024

Senate

SIGNED CHAP.152

Senate

DELIVERED TO GOVERNOR

Jun 06, 2024

Assembly

PASSED ASSEMBLY

Assembly

RETURNED TO SENATE

Jun 03, 2024

Assembly

SUBSTITUTED FOR A1619A

Assembly

ORDERED TO THIRD READING RULES CAL.301

May 30, 2024

Senate

REPASSED SENATE

Assembly

REFERRED TO WAYS AND MEANS

Senate

RETURNED TO ASSEMBLY

May 23, 2024

Senate

RECALLED FROM ASSEMBLY

Senate

AMENDED ON THIRD READING (T) 1001A

Senate

VOTE RECONSIDERED - RESTORED TO THIRD READING

Assembly

RETURNED TO SENATE

Mar 20, 2024

Senate

DELIVERED TO ASSEMBLY

Senate

PASSED SENATE

Assembly

REFERRED TO INSURANCE

Jan 24, 2024

Senate

ADVANCED TO THIRD READING

Jan 23, 2024

Senate

2ND REPORT CAL.

Jan 22, 2024

Senate

1ST REPORT CAL.164

Jan 03, 2024

Assembly

DIED IN ASSEMBLY

Senate

REFERRED TO HEALTH

Assembly

RETURNED TO SENATE

Jun 06, 2023

Senate

DELIVERED TO ASSEMBLY

Assembly

REFERRED TO INSURANCE

Senate

PASSED SENATE

May 30, 2023

Senate

ADVANCED TO THIRD READING

May 24, 2023

Senate

2ND REPORT CAL.

May 23, 2023

Senate

1ST REPORT CAL.1325

Jan 09, 2023

Senate

REFERRED TO HEALTH

Bill Text

Bill Text Versions Format
S1001 PDF HTML
S1001A PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.